node1	node2	edge_score	
DB13961	PTGS2	1.0	
DB13961	PPARG	1.0	
DB13961	PPARD	1.0	
DB13961	SREBF1	1.0	
DB13961	PPARA	1.0	
DB13961	CYP3A4	1.0	
PTGS2	rs12042763	0.99
CYP3A4	rs35599367	0.99
PPARA	rs4823613	0.99
CYP3A4	rs2242480	0.99
PPARD		1.0
rs2740574	CYP3A	0.9801
PPARA	rs4253778	0.99
CYP3A4	rs4646437	0.99
PPARA	rs149711321	0.99
PPARA	rs4253728	0.99
PTGS2		1.0
CYP3A4	rs2246709	0.99
CYP3A	rs12721627	0.970299
PPARD	rs3734254	0.99
CYP3A4	CYP3A4*1, CYP3A4*4	0.99
rs4987161	CYP3A	0.9801
rs12721627	CYP3A	0.9801
PPARG		1.0
CYP3A4	rs3735451	0.99
PPARA	rs9626730	0.99
PPARA		1.0
CYP3A4		1.0
rs12721627	CYP3A4	0.96059601
PTGS2	rs20417	0.99
CYP3A4	rs4987161	0.99
CYP3A4	CYP3A4*1, CYP3A4*22	0.99
CYP3A	rs2740574	0.970299
PPARA	rs135550	0.99
PPARD	rs6922548	0.99
rs4987161	CYP3A4	0.96059601
CYP3A4	rs2740574	0.99
rs2740574	CYP3A4	0.96059601
CYP3A4	rs28371759	0.99
CYP3A4	rs4986910	0.99
CYP3A	rs4987161	0.970299
CYP3A4	CYP3A4*1, CYP3A4*20, CYP3A4*8	0.99
PTGS2	rs5275	0.99
PPARD	rs1883322	0.99
PPARD	rs7769719	0.99
PPARD	rs2016520	0.99
PPARA	rs135543	0.99
CYP3A4	rs4646440	0.99
CYP3A4	rs12721627	0.99
PTGS2	rs4648287	0.99
SREBF1		1.0
CYP3A4	CYP3A4*1, CYP3A4*1G	0.99
CYP3A4	rs56324128	0.99
Dyslipidemias	CYP3A4	1.0	
Dyslipidemias	PPARA	1.0	
Dyslipidemias	PPARD	1.0	
Dyslipidemias	PPARG	1.0	
Dyslipidemias	PTGS2	1.0	
Dyslipidemias	SREBF1	1.0	
Bone necrosis	CYP3A4	1.0	
Bone necrosis	PPARG	1.0	
Bone necrosis	SREBF1	1.0	
Overweight	PPARA	1.0	
Overweight	PPARD	1.0	
Overweight	PPARG	1.0	
Overweight	PTGS2	1.0	
Overweight	SREBF1	1.0	
Steatohepatitis	CYP3A4	1.0	
Steatohepatitis	PPARA	1.0	
Steatohepatitis	PPARD	1.0	
Steatohepatitis	PPARG	1.0	
Steatohepatitis	SREBF1	1.0	
gliosarcoma	CYP3A4	1.0	
gliosarcoma	PPARG	1.0	
gliosarcoma	PTGS2	1.0	
Hepatic steatosis	CYP3A4	1.0	
Hepatic steatosis	PPARA	1.0	
Hepatic steatosis	PPARD	1.0	
Hepatic steatosis	PPARG	1.0	
Hepatic steatosis	PTGS2	1.0	
Hepatic steatosis	SREBF1	1.0	
Hyperlipidemia, combined, 1	CYP3A4	1.0	
Hyperlipidemia, combined, 1	PPARA	1.0	
Hyperlipidemia, combined, 1	PPARD	1.0	
Hyperlipidemia, combined, 1	PPARG	1.0	
Hyperlipidemia, combined, 1	SREBF1	1.0	
Non-alcoholic Fatty Liver Disease	CYP3A4	1.0	
Non-alcoholic Fatty Liver Disease	PPARA	1.0	
Non-alcoholic Fatty Liver Disease	PPARD	1.0	
Non-alcoholic Fatty Liver Disease	PPARG	1.0	
Non-alcoholic Fatty Liver Disease	SREBF1	1.0	
Liver regeneration disorder	PPARA	1.0	
Liver regeneration disorder	PPARD	1.0	
Liver regeneration disorder	PPARG	1.0	
Type 1 diabetic neuropathy	PPARG	1.0	
Type 1 diabetic neuropathy	PTGS2	1.0	
Type 1 diabetic neuropathy	SREBF1	1.0	
Thyroid associated opthalmopathies	PPARA	1.0	
Thyroid associated opthalmopathies	PPARG	1.0	
Thyroid associated opthalmopathies	PTGS2	1.0	
Femur Head Necrosis	CYP3A4	1.0	
Femur Head Necrosis	SREBF1	1.0	
Squamous Cell Neoplasms	CYP3A4	1.0	
Squamous Cell Neoplasms	PTGS2	1.0	
Anterior myocardial infarction	PPARG	1.0	
Anterior myocardial infarction	PTGS2	1.0	
Enzyme inhibition disorder	CYP3A4	1.0	
Enzyme inhibition disorder	PTGS2	1.0	
Hypercholesterolemia, autosomal dominant, type B	CYP3A4	1.0	
Hypercholesterolemia, autosomal dominant, type B	PPARA	1.0	
Hypercholesterolemia, autosomal dominant, type B	PPARG	1.0	
Hypercholesterolemia, autosomal dominant, type B	SREBF1	1.0	
Neoplasm of the rectum	PPARD	1.0	
Neoplasm of the rectum	PPARG	1.0	
Neoplasm of the rectum	PTGS2	1.0	
Acute postoperative pain	CYP3A4	1.0	
Acute postoperative pain	PTGS2	1.0	
Lipoidosis	PPARG	1.0	
Lipoidosis	SREBF1	1.0	
Disorders of Intracellular Cobalamin Metabolism	CYP3A4	1.0	
Disorders of Intracellular Cobalamin Metabolism	PPARA	1.0	
Disorders of Intracellular Cobalamin Metabolism	PPARD	1.0	
Disorders of Intracellular Cobalamin Metabolism	PPARG	1.0	
Disorders of Intracellular Cobalamin Metabolism	SREBF1	1.0	
Knee osteoarthritis	PPARA	1.0	
Knee osteoarthritis	PPARG	1.0	
Knee osteoarthritis	PTGS2	1.0	
Hypertriglyceridemia	PPARA	1.0	
Hypertriglyceridemia	PPARG	1.0	
Hypertriglyceridemia	SREBF1	1.0	
Obesity, Visceral	PPARA	1.0	
Obesity, Visceral	SREBF1	1.0	
Monocytic leukemia	PPARG	1.0	
Monocytic leukemia	PTGS2	1.0	
Hypertriglyceridemia result	PPARA	1.0	
Hypertriglyceridemia result	PPARG	1.0	
Kidney Failure, Chronic	CYP3A4	1.0	
Kidney Failure, Chronic	PPARA	1.0	
Kidney Failure, Chronic	PPARD	1.0	
Kidney Failure, Chronic	PPARG	1.0	
Kidney Failure, Chronic	PTGS2	1.0	
Kidney Failure, Chronic	SREBF1	1.0	
Pediatric Obesity	PPARA	1.0	
Pediatric Obesity	PPARG	1.0	
Obesity, severe, 601665 (3)	PPARA	1.0	
Obesity, severe, 601665 (3)	PPARD	1.0	
Obesity, severe, 601665 (3)	PPARG	1.0	
Insulin resistance syndrome	PPARA	1.0	
Insulin resistance syndrome	PPARG	1.0	
Metabolic Syndrome X	CYP3A4	1.0	
Metabolic Syndrome X	PPARA	1.0	
Metabolic Syndrome X	PPARD	1.0	
Metabolic Syndrome X	PPARG	1.0	
Metabolic Syndrome X	PTGS2	1.0	
Metabolic Syndrome X	SREBF1	1.0	
Acute hepatic failure	CYP3A4	1.0	
Acute hepatic failure	PPARA	1.0	
Acute hepatic failure	PTGS2	1.0	
Coronary Restenosis	PPARA	1.0	
Coronary Restenosis	PPARG	1.0	
Endometrial Neoplasms	CYP3A4	1.0	
Endometrial Neoplasms	PPARG	1.0	
Endometrial Neoplasms	PTGS2	1.0	
Endometrial Neoplasms	SREBF1	1.0	
Acute kidney injury	CYP3A4	1.0	
Acute kidney injury	PPARA	1.0	
Acute kidney injury	PPARG	1.0	
Acute kidney injury	PTGS2	1.0	
Left ventricular hypertrophy	PPARA	1.0	
Left ventricular hypertrophy	PPARD	1.0	
Left ventricular hypertrophy	PPARG	1.0	
Left ventricular hypertrophy	PTGS2	1.0	
Pain insensitivity	CYP3A4	1.0	
Pain insensitivity	PPARA	1.0	
